A Hidden ORF Reveals a New Immune Protector

Por Chu, Qian, Saghatelian, Alan
Publicado no Biochemistry (2019)

Discovery and Characterization of A Novel Class of Functional Polypeptides

Por Chu, Qian, Ma, Jiao, Saghatelian, Alan
Publicado no Crit Rev Biochem Mol Biol (2015)

The role of gut microbiota in immune checkpoint inhibitor therapy

Por Yi, Ming, Qin, Shuang, Chu, Qian, Wu, Kongming
Publicado no Hepatobiliary Surg Nutr (2018)

Immune pressures drive the promoter hypermethylation of neoantigen genes

Por Yi, Ming, Dong, Bing, Chu, Qian, Wu, Kongming
Publicado no Exp Hematol Oncol (2019)

The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury

Por Huang, Shanshan, Che, Jing, Chu, Qian, Zhang, Peng
Publicado no Front Cell Dev Biol (2020)

Small, but mighty? Searching for human microproteins and their potential for understanding health and disease

Por Rathore, Annie, Martinez, Thomas F., Chu, Qian, Saghatelian, Alan
Publicado no Expert Rev Proteomics (2018)

4,4′-Methyl­enedianilinium bis­(3-carb­oxy-4-hydroxy­benzene­sulfonate) monohydrate

Por Du, Guihuan, Liu, Zuli, Chu, Qian, Li, Zhen, Zhang, Suming
Publicado em 2008

Bis(4-methyl­imidazolium) succinate succinic acid solvate

Por Du, Guihuan, Liu, Zuli, Chu, Qian, Li, Zhen, Zhang, Suming
Publicado em 2009

Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor

Por Bai, Xianguang, Yi, Ming, Jiao, Ying, Chu, Qian, Wu, Kongming
Publicado no Onco Targets Ther (2019)

Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation

Por Qin, Shuang, Dong, Bing, Yi, Ming, Chu, Qian, Wu, Kongming
Publicado no Front Oncol (2020)

Relationship between encephalopathy and portal vein-vena cava shunt: Value of computed tomography during arterial portography

Por Chu, Qian, Li, Zhen, Zhang, Su-Ming, Hu, Dao-Yu, Xiao, Ming
Publicado no World J Gastroenterol (2004)

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers

Por Tian, Yijun, Liu, Qian, Wu, Kongju, Chu, Qian, Chen, Yuan, Wu, Kongming
Publicado no Oncotarget (2017)

EGFR-TKIs resistance via EGFR-independent signaling pathways

Por Liu, Qian, Yu, Shengnan, Zhao, Weiheng, Qin, Shuang, Chu, Qian, Wu, Kongming
Publicado no Mol Cancer (2018)

The role of neoantigen in immune checkpoint blockade therapy

Por Yi, Ming, Qin, Shuang, Zhao, Weiheng, Yu, Shengnan, Chu, Qian, Wu, Kongming
Publicado no Exp Hematol Oncol (2018)

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine

Por Xu, Hanxiao, Jiao, Ying, Qin, Shuang, Zhao, Weiheng, Chu, Qian, Wu, Kongming
Publicado no Exp Hematol Oncol (2018)

Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment

Por Yi, Ming, Jiao, Dechao, Qin, Shuang, Chu, Qian, Wu, Kongming, Li, Anping
Publicado no Mol Cancer (2019)

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

Por Li, Anping, Yi, Ming, Qin, Shuang, Song, Yongping, Chu, Qian, Wu, Kongming
Publicado no J Hematol Oncol (2019)

Prospects for combining immune checkpoint blockade with PARP inhibition

Por Li, Anping, Yi, Ming, Qin, Shuang, Chu, Qian, Luo, Suxia, Wu, Kongming
Publicado no J Hematol Oncol (2019)

The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis

Por Wu, Kongju, Yi, Ming, Qin, Shuang, Chu, Qian, Zheng, Xinhua, Wu, Kongming
Publicado no Exp Hematol Oncol (2019)

Advances and perspectives of PARP inhibitors

Por Yi, Ming, Dong, Bing, Qin, Shuang, Chu, Qian, Wu, Kongming, Luo, Suxia
Publicado no Exp Hematol Oncol (2019)